botensilimab,balstilimab
agenus
[]
 why doesn't it make sense? surely not yet enough for an approval due to fda statistical requirements, but all data are convergent in all type of tumors. note that these are heavily pre-treated patients and/or 'cold' tumors, that with other io give a poor 1 digit %.
amazing